Response to Comments on "Immunogenicity and Safety of Intradermal Trivalent Influenza Vaccination in Nursing Home Older Adults: A Randomized Controlled Trial"

Journal of the American Medical Directors Association

Volumn 15, Issue 10, 2014, Pages 773-774

  Chan, Tuen Ching ^a   Hung, Ivan Fan Ngai ^b   Chan, Kwok Hung ^b   Li, Clara Pui Yan ^b   Li, Patrick Tsz Wai ^b   Luk, James Ka Hay ^c   Chu, Leung Wing ^b   Chan, Felix Hon Wai ^c  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c TWGHs Fung Yiu King Hospital   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; DRUG DELIVERY DEVICE; GROUPS BY AGE; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; LETTER; NEEDLE; NURSING HOME PATIENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUBCUTANEOUS TISSUE; VACCINATION REACTION; FEMALE; IMMUNOLOGY; INFLUENZA, HUMAN; MALE; NURSING HOME; PATIENT SAFETY;

FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; NURSING HOMES; PATIENT SAFETY;

EID: 84927625138     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2014.07.014     Document Type: Letter

References (6)

1. Chi R.C., Rock M.T., Neuzil K.M. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults. Clin Infect Dis 2010, 50:1331-1338.
2. Levin Y., Kochba E., Kenney R. Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: Are all delivery methods the same?. Vaccine 2014, 32:4249-4252.
3. Hung I.F.N., Levin Y., To K.K.W., et al. Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain. Vaccine 2012, 30:6427-6435.
4. Chan T.C., Hung I.F.N., Chan K.H., et al. Immunogenicity and safety of intradermal trivalent influenza vaccination in nursing home older adults: A randomized controlled trial. JAm Med Dir Assoc 2014, 15:607.e5-607.e12.
5. Moro P.L., Harrington T., Shimabukuro T., et al. Adverse events after Fluzone Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011-2013. Vaccine 2013, 31:4984-4987.
6. Durando P., Alicino C., Alberti M., et al. Acceptance and safety of the intradermal influenza vaccine among the elderly in Italy: An on-field national study. Adv Ther 2012, 29:312-326.